Open AccessIncidence and Survival of Hepatocellular Carcinoma in Type 2 Diabetes Patients with Cirrhosis Who Were Treated with and without Metformin
Author(s) -
Thanida Tangjarusritaratorn,
Watip Tangjittipokin,
Tada Kunavisarut
Publication year - 2021
Publication title -
diabetes, metabolic syndrome and obesity
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.853
H-Index - 43
ISSN - 1178-7007
DOI - 10.2147/dmso.s295753
Subject(s) - metformin , medicine , cirrhosis , hepatocellular carcinoma , diabetes mellitus , incidence (geometry) , gastroenterology , univariate analysis , multivariate analysis , endocrinology , insulin , physics , optics
To evaluate metformin's benefit on the incidence and survival of hepatocellular carcinoma (HCC) in cirrhosis with type 2 diabetes mellitus (T2DM) patients.